General Biologicals Stock Forecast - Naive Prediction
| 4117 Stock | TWD 12.20 0.10 0.81% |
The Naive Prediction forecasted value of General Biologicals on the next trading day is expected to be 12.30 with a mean absolute deviation of 0.32 and the sum of the absolute errors of 11.27. General Stock Forecast is based on your current time horizon.
As of today the value of rsi of General Biologicals' share price is below 20 . This suggests that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using General Biologicals hype-based prediction, you can estimate the value of General Biologicals from the perspective of General Biologicals response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of General Biologicals on the next trading day is expected to be 12.30 with a mean absolute deviation of 0.32 and the sum of the absolute errors of 11.27. General Biologicals after-hype prediction price | TWD 12.2 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
General |
General Biologicals Additional Predictive Modules
Most predictive techniques to examine General price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for General using various technical indicators. When you analyze General charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
General Biologicals Naive Prediction Price Forecast For the 21st of January
Given 90 days horizon, the Naive Prediction forecasted value of General Biologicals on the next trading day is expected to be 12.30 with a mean absolute deviation of 0.32, mean absolute percentage error of 0.32, and the sum of the absolute errors of 11.27.Please note that although there have been many attempts to predict General Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that General Biologicals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
General Biologicals Stock Forecast Pattern
| Backtest General Biologicals | General Biologicals Price Prediction | Buy or Sell Advice |
General Biologicals Forecasted Value
In the context of forecasting General Biologicals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. General Biologicals' downside and upside margins for the forecasting period are 6.45 and 18.15, respectively. We have considered General Biologicals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of General Biologicals stock data series using in forecasting. Note that when a statistical model is used to represent General Biologicals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 69.1843 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.322 |
| MAPE | Mean absolute percentage error | 0.0244 |
| SAE | Sum of the absolute errors | 11.2692 |
Predictive Modules for General Biologicals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as General Biologicals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for General Biologicals
For every potential investor in General, whether a beginner or expert, General Biologicals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. General Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in General. Basic forecasting techniques help filter out the noise by identifying General Biologicals' price trends.General Biologicals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with General Biologicals stock to make a market-neutral strategy. Peer analysis of General Biologicals could also be used in its relative valuation, which is a method of valuing General Biologicals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
General Biologicals Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of General Biologicals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of General Biologicals' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
General Biologicals Market Strength Events
Market strength indicators help investors to evaluate how General Biologicals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading General Biologicals shares will generate the highest return on investment. By undertsting and applying General Biologicals stock market strength indicators, traders can identify General Biologicals entry and exit signals to maximize returns.
| Accumulation Distribution | 2591.5 | |||
| Daily Balance Of Power | (0.29) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 12.18 | |||
| Day Typical Price | 12.18 | |||
| Price Action Indicator | (0.03) | |||
| Period Momentum Indicator | (0.10) |
General Biologicals Risk Indicators
The analysis of General Biologicals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in General Biologicals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting general stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.76 | |||
| Standard Deviation | 5.85 | |||
| Variance | 34.2 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with General Biologicals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if General Biologicals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in General Biologicals will appreciate offsetting losses from the drop in the long position's value.Moving against General Stock
| 0.41 | 1734 | Sinphar Pharmaceutical | PairCorr |
| 0.39 | 4160 | Genetics Generation | PairCorr |
| 0.35 | 2913 | Taiwan Tea Corp | PairCorr |
| 0.35 | 4109 | Jia Jie Biomedical | PairCorr |
The ability to find closely correlated positions to General Biologicals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace General Biologicals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back General Biologicals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling General Biologicals to buy it.
The correlation of General Biologicals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as General Biologicals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if General Biologicals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for General Biologicals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for General Stock Analysis
When running General Biologicals' price analysis, check to measure General Biologicals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy General Biologicals is operating at the current time. Most of General Biologicals' value examination focuses on studying past and present price action to predict the probability of General Biologicals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move General Biologicals' price. Additionally, you may evaluate how the addition of General Biologicals to your portfolios can decrease your overall portfolio volatility.